Strategic Partnerships Mobility Health has established collaborations with Intend, Inc. and CPESN USA to expand access to rapid infectious disease testing. This indicates an openness to channel partnerships and pharmacy-based testing programs, presenting an opportunity to offer integrated testing platforms, payer-ready solutions, and nationwide pharmacy network deployments.

Pharmacy Focus The company targets community-based and pharmacy networks to deliver molecular testing, suggesting sales opportunities around pharmacy affinity programs, mobile testing capabilities, and point-of-care diagnostics that fit into pharmacy workflow and patient outreach initiatives.

Rapid Molecular With a mission centered on accurate, rapid molecular testing and mobile capabilities, there is a fit for selling scalable diagnostic tech, sample-to-result workflows, and portable lab solutions tailored for underserved communities and point-of-care settings.

Growth Constraints Current revenue is under one million with a small team, indicating a lean operation that could benefit from scalable enterprise solutions, streamlined implementation services, and partner-led go-to-market packages to accelerate adoption without overburdening resources.

Strategic Leadership Led by Sandra Gunselman, Ph.D., the company combines molecular biology expertise with laboratory operations know-how. This presents opportunities to position senior-level collaboration, co-development of testing protocols, and joint-education initiatives to drive trust and adoption in target networks.